Estradiol vaginal cream

DRUG4 trials

Sponsors

CONRAD, Prasco LLC, University of South Florida, Wake Forest University Health Sciences

Conditions

HIV PreventionPelvic Organ ProlapsePessary Ulcer of VaginaRecurrent Urinary Tract InfectionUrinary IncontinenceVaginal AtrophyVulvar and Vaginal Atrophy

Early Phase 1

Vaginal Estradiol Use in Pessary Care

TerminatedNCT05458375

University of South FloridaPelvic Organ Prolapse, Pessary Ulcer of Vagina, Urinary Incontinence +1

Start: 2022-12-29End: 2023-04-26Updated: 2023-05-11

Phase 1

Influence of Reproductive Cycle and Menopause on HIV-1 Infection and TFV Gel Activity

CompletedNCT01810315

CONRADHIV Prevention

Start: 2013-09-30End: 2014-10-31Updated: 2015-04-10

Phase 3

Study to Evaluate the Equivalence of Estradiol Vaginal Cream to Reference Standard in the Treatment of Vaginal Atrophy

CompletedNCT03332303

Prasco LLCVulvar and Vaginal Atrophy

Start: 2017-10-26End: 2018-03-15Updated: 2024-05-30

Phase 4

Preference of Women With Recurrent Urinary Tract Infection for Vaginal Estradiol Tablet vs Cream

Active, not recruitingNCT05723601

Wake Forest University Health SciencesRecurrent Urinary Tract Infection

Start: 2024-01-12End: 2027-01-31Updated: 2025-12-02